The primary aim of this discussion paper is to assess the usefulness of the anti-Müllerian hormone assay procedure (AMH) with a view to its inclusion in the NABM (Nomenclature of Procedures in Laboratory Medicine).
See also
HAS opinions and decisions
26/07/2017
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
Muv1XF8xW1725Dha